Progressive Differentiated Thyroid Cancer: Best Use of the Tyrosine Kinase Inhibitors

Abstract: Thyroid cancer has one of the best overall survival rates among all malignancies, but it has a high incidence. There are various subtypes of thyroid cancer. […]

The Changing Landscape in the Frontline Treatment of Chronic Lymphocytic Leukemia

Volume 14, Issue 5, Supplement 8 May 2016 Discussants John M. Pagel, MD, PhD Chief, Hematologic Malignancies Director, Hematopoietic Stem Cell Transplantation Program Swedish Cancer Institute […]

Highlights in GEP-NETs From the 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease

Volume 14, Issue 5, Supplement 7 May 2016 Highlights in GEP-NETs From the 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease […]

Back to Archive